Company / Cost of Revenue
Thermo Fisher Scientific Cost of Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$9.0B
FY2017
5-year range
-
FY2016-FY2017
Trend
+9.3%
vs FY2016
Sector context
#16 of 113
Health Care
What the data says
Thermo Fisher Scientific's cost of revenue of $9.0B is higher than 86% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$9.0B in FY2017. Top quartile in the Health Care sector.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 113This company $9.0B Sector average $11.3B
▼
-20.5% below sector average
Key checks
Key Insights
- In FY2017, cost of revenue increased 9.3% year-over-year.
- Ranks #16 out of 113 companies in the Health Care sector.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $9.0B | +9.3% |
| FY2016 | $8.2B | +8.3% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026